Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/27/2003 | WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
03/27/2003 | WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
03/27/2003 | WO2003025131A2 Protein modification and maintenance molecules |
03/27/2003 | WO2003025129A2 Neurotransmission-associated proteins |
03/27/2003 | WO2003025124A2 Immunoglobulin having particular framework scaffold and methods of making and using |
03/27/2003 | WO2003025120A2 Clasp membrane proteins |
03/27/2003 | WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
03/27/2003 | WO2003025020A1 Method of constructing camel antibody library |
03/27/2003 | WO2003025019A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
03/27/2003 | WO2003025018A2 Dimeric and multimeric antigen binding structure |
03/27/2003 | WO2003025015A2 A soluble toll-like receptor |
03/27/2003 | WO2003025009A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY |
03/27/2003 | WO2003025002A2 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection |
03/27/2003 | WO2003024994A1 Detection and treatment of cancers of the lung |
03/27/2003 | WO2003024989A2 Activation and expansion of cells |
03/27/2003 | WO2003024482A1 Crustaceans as production systems for therapeutic proteins |
03/27/2003 | WO2003024399A2 Specific depletion of cd4+t cells |
03/27/2003 | WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor |
03/27/2003 | WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma |
03/27/2003 | WO2003024304A2 Detection and treatment of cancers of the liver |
03/27/2003 | WO2003024302A2 Detection and treatment of cancers of breast |
03/27/2003 | WO2003024191A2 Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
03/27/2003 | WO2003005033A8 Carcinoma-related peptides |
03/27/2003 | WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use |
03/27/2003 | WO2002092837A9 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy |
03/27/2003 | WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals |
03/27/2003 | WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response |
03/27/2003 | WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae) |
03/27/2003 | WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
03/27/2003 | WO2002046414A3 Human g-protein coupled receptor expressed highly in kidney |
03/27/2003 | WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts |
03/27/2003 | WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
03/27/2003 | WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/27/2003 | WO2002029060A3 Hematopoietin receptors hpr1 and hpr2 |
03/27/2003 | WO2002026951A3 Oxidoreductases |
03/27/2003 | WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
03/27/2003 | WO2002022684A3 Transporters and ion channels |
03/27/2003 | WO2002018954A9 Inhibition of cmv infection and dissemination |
03/27/2003 | WO2002016585A3 Imidazoline receptor homologs |
03/27/2003 | WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof |
03/27/2003 | WO2002015932A9 Methods for treating demyelinating diseases |
03/27/2003 | WO2002012340A3 Transporters and ion channels |
03/27/2003 | WO2002011667A3 Pharmaceutical compositions and methods useful for modulating angiogenesis |
03/27/2003 | WO2001088538A3 Compositions and methods for epitope mapping |
03/27/2003 | WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer |
03/27/2003 | WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
03/27/2003 | US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders |
03/27/2003 | US20030060616 Type II IL-1 receptors |
03/27/2003 | US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
03/27/2003 | US20030060603 Generation of preferential antibodies in vertebrates; obtain cells, transfrom with expression vector coding antibody, express vector, recover antibody |
03/27/2003 | US20030060602 Polypeptide for use in human therapeutics and diagnostics |
03/27/2003 | US20030060601 Polypeptide for use in human therapeutics and diagnostics |
03/27/2003 | US20030060600 Polypeptide for use in human therapeutics and diagnostics |
03/27/2003 | US20030060512 Modulation of inflammation related to columnar epithelia |
03/27/2003 | US20030060444 In which an effector cell is transformed with DNA coding for chimeric receptor containing two or more cytoplasmic signalling components derived from tetraspan-transmembrane protein or antigens; anticancer agents |
03/27/2003 | US20030060432 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
03/27/2003 | US20030060410 Use of HMG fragments as anti-inflammatory agents |
03/27/2003 | US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist |
03/27/2003 | US20030060405 Administering to the subject a composition containing the amino acid sequence hexapeptide |
03/27/2003 | US20030060401 Genetic engineered drug |
03/27/2003 | US20030059951 Maternal status testing in animals |
03/27/2003 | US20030059937 Antibodies that immunospecifically bind BLyS |
03/27/2003 | US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
03/27/2003 | US20030059912 Hybrid ptorin for use in treating allergies and controlling immunogical response |
03/27/2003 | US20030059911 Modulator of transcription factor activity for use in the treatment of immune response, stress responses, inflammation or apoptotic disorders |
03/27/2003 | US20030059910 Oil bodies and associated proteins as affinity matrices |
03/27/2003 | US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders |
03/27/2003 | US20030059894 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of lyme disease |
03/27/2003 | US20030059888 Vector for use as gene transfer and diagnostic tool in genetic enginering |
03/27/2003 | US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
03/27/2003 | US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
03/27/2003 | US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059871 Hematopoietin receptors HPR1 and HPR2 |
03/27/2003 | US20030059869 Novel G protein-coupled receptor, GAVE3 |
03/27/2003 | US20030059864 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
03/27/2003 | US20030059862 Antibodies against tumor necrosis factor delta (APRIL) |
03/27/2003 | US20030059859 Vertebrate protein for use in human therapeutic and diagnostics |
03/27/2003 | US20030059842 Diagnostic kit for predicting the onset of menopause |
03/27/2003 | US20030059841 Methods of using bioelastomers |
03/27/2003 | US20030059840 Methods of using bioelastomers |
03/27/2003 | US20030059838 Monoclonal antibody for use as diagnostic tool in gene therapy |
03/27/2003 | US20030059834 Generating monoclonal antibodies; obtain nucleotide sequences from library, clone, transduce or transfect cells, isolate lymphocyte, recover monoclonal abtibodies |
03/27/2003 | US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
03/27/2003 | US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
03/27/2003 | US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
03/27/2003 | US20030059829 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders |
03/27/2003 | US20030059828 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders |
03/27/2003 | US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof |
03/27/2003 | US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans |
03/27/2003 | US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
03/27/2003 | US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases |
03/27/2003 | US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases |
03/27/2003 | US20030059772 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/27/2003 | US20030059512 Cross-flow filtration, chromatography and fermentation to separate and fully utilize the components |
03/27/2003 | US20030059444 Mucosal vaccine for Neisseria based on native outer membrane vesicles prepared from genetically engineered vaccine strain and unexposed to detergents |